logo
Plus   Neg
Share
Email

Roche Gets CE Mark For Its Accu-Chek SugarView App - Quick Facts

Swiss drug maker Roche Group (RHHBY) announced Tuesday that it has obtained the CE Mark for its Accu-Chek SugarView app, which is designed to help non-insulin-dependent people with type 2 diabetes or pre-diabetes.

The company noted that Accu-Chek SugarView is the first app that determines blood glucose ranges by taking photos with the smartphone camera without the need of a blood glucose meter.

The app is now officially classified as in-vitro diagnostics or IVD software. Roche will make the app widely accessible first for certain smartphone models through the Google Play Store. It will provide broader access to therapy relevant information for non-insulin dependent people with type 2 diabetes or pre-diabetes.

With the mark, the company now could launch its diabetes management solution in Europe and further countries around the world requiring the CE Mark.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT